Related Experiment Video

Updated: Jun 13, 2026

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Isolated central nervous system recurrence in a child with stage IV neuroblastoma

Vasiliki Sidi-Fragandrea1, Emmanouil Hatzipantelis, Paraskevi Panagopoulou

  • 1Department of Paediatric Oncology, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.

Pediatric Hematology and Oncology
|May 18, 2010
PubMed

Insights

Neuroblastoma, a common childhood cancer, can rarely relapse in the central nervous system (CNS). Early detection through MRI is crucial for high-risk patients with prolonged survival.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Metastasis

Background:

  • Neuroblastoma is the most frequent extracranial solid tumor in children.
  • Improved survival rates are attributed to aggressive chemotherapy and bone marrow transplantation.
  • Typical recurrence sites include primary tumor, bone, liver, and lungs.

Observation:

  • A case of stage IV extracerebral neuroblastoma with isolated central nervous system (CNS) relapse is presented.
  • This CNS relapse led to the patient's death.
  • CNS relapse is uncommon but increasingly recognized due to improved patient survival.

Findings:

  • The central nervous system (CNS) is an increasingly diagnosed, albeit rare, site for neuroblastoma relapse.
  • Prolonged survival in neuroblastoma patients contributes to the rising incidence of CNS relapse.
  • There is an urgent need for criteria to identify patients at higher risk for CNS relapse.

Implications:

  • Identifying high-risk patients for CNS relapse is critical.
  • Regular brain and spine magnetic resonance imaging (MRI) is recommended for high-risk individuals.
  • Timely detection and management of CNS metastases can improve outcomes for neuroblastoma patients.

More Related Videos

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...